Meeting
2015 Gastrointestinal Cancers Symposium
The difference between the subjective and objective evaluation of oxaliplatin-induced vascular pain due to administer chemotherapy via peripheral vein.
Authors
Naoya Aisu
Department of Gastroenterological Surgery, Fukuoka University School of Medicine, Fukuoka, Japan
Naoya Aisu , Yoichiro Yoshida , Teppei Yamada , Taisuke Matsuoka , Daibo Kojima , Syu Tanimura , Seiichiro Hoshino , Ai Mogi , Tomoko Koganemaru , Mayumi Oda , Mahiru Fukuda , Fumiaki Kiyomi , Keita Noda , Keiji Hirata , Kazuo Tamura , Yuichi Yamashita
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 651)
DOI
10.1200/jco.2015.33.3_suppl.651
Abstract #
651
Poster Bd #
C43
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Steroid-free regimen with aprepitant in preventing chemotherapy-induced nausea and vomiting in patients with colorectal cancer receiving FOLFOX chemotherapy: A randomized phase III trial.
First Author: Wenjing Wang
Poster
2015 Gastrointestinal Cancers Symposium
Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy.
First Author: Teppei Yamada
Poster
2011 ASCO Annual Meeting
Phase III study of single-dose casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting.
First Author: P. J. Hesketh
Poster
2024 ASCO Annual Meeting
Prospective evaluation of the effect of 3 days of post-chemotherapy dexamethasone on patient reported symptoms in gynecologic oncology patients treated with carboplatin and paclitaxel.
First Author: Hayley Hart